Drug Costs Not A Primary Driver Of Rare Disease Economic Burden

 
• By Derrick Gingery
  
Rare Disease ribbon
The National Economic Burden of Rare Disease Study is not intended drive research or drug development in a particular disease area. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet